Toggle light / dark theme

Senescence field has “completely exploded”

SENS founder Aubrey de Grey expects senescence-targeting sector will see Phase 3 trials within “a couple of years”.

Leave a Comment

If you are already a member, you can use this form to update your payment info.

Lifeboat Foundation respects your privacy! Your email address will not be published.